Literature DB >> 22065152

Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin.

Annika Fahlén1, Lars Engstrand, Barbara S Baker, Anne Powles, Lionel Fry.   

Abstract

Microorganisms have been implicated in the pathogenesis of psoriasis. Previous studies of psoriasis and normal skin have used swabs from the surface rather than skin biopsies. In this study, biopsies were taken from 10 patients with psoriasis and 12 control subjects from unmatched sites. Samples were analysed with massive parallel pyrosequencing on the 454 platform targeting the 16S rRNA gene and the variable regions V3-V4. The samples grouped into 19 phyla, 265 taxon and 652 operational units (OTUs) at 97% identity. A cut-off abundance level was set at 1%. The three most common phyla in both normal and psoriasis skin were Firmicutes (39% psoriasis, 43% normal skin), Proteobacteria (38% psoriasis, 27% normal skin) and Actinobacteria (5% psoriasis, 16% normal skin, p = 0.034). In trunk skin, Proteobacteria were present at significantly higher levels in psoriasis compared to controls (52 vs. 32%, p = 0.0113). The commonest genera were Streptococci in both psoriasis (32%) and normal skin (26%). Staphylococci were less common in psoriasis (5%) than in controls (16%), as were Propionibacteria (psoriasis 0.0001669%, controls 0.0254%). Both Staphylococci and Propionibacteria were significantly lower in psoriasis versus control limb skin (p = 0.051, 0.046, respectively). This study has shown some differences in microbiota between psoriasis and normal skin. Whether these are of primary aetiological significance, or secondary to the altered skin of psoriasis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065152     DOI: 10.1007/s00403-011-1189-x

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  83 in total

Review 1.  Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory.

Authors:  W M Dunne; L F Westblade; B Ford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-08       Impact factor: 3.267

2.  Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttata.

Authors:  Lei Qian; Wei Chen; Wen Sun; Ming Li; Renshan Zheng; Qing Qian; Lianzheng Lv
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 3.  Microbial ecology of the skin in the era of metagenomics and molecular microbiology.

Authors:  Geoffrey D Hannigan; Elizabeth A Grice
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

4.  What Lives On Our Skin: Ecology, Genomics and Therapeutic Opportunities Of the Skin Microbiome.

Authors:  Tiffany C Scharschmidt; Michael A Fischbach
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01

5.  Immunity to commensal skin fungi promotes psoriasiform skin inflammation.

Authors:  Charlotte Hurabielle; Verena M Link; Nicolas Bouladoux; Seong-Ji Han; Eric Dean Merrill; Yaima L Lightfoot; Nickie Seto; Christopher K E Bleck; Margery Smelkinson; Oliver J Harrison; Jonathan L Linehan; Samira Tamoutounour; Michail S Lionakis; Mariana J Kaplan; Saeko Nakajima; Yasmine Belkaid
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

Review 6.  Biodiversity and functional genomics in the human microbiome.

Authors:  Xochitl C Morgan; Nicola Segata; Curtis Huttenhower
Journal:  Trends Genet       Date:  2012-11-07       Impact factor: 11.639

Review 7.  The price of immunity.

Authors:  Romina S Goldszmid; Giorgio Trinchieri
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

8.  The Role of the Skin and Gut Microbiome in Psoriatic Disease.

Authors:  Di Yan; Naiem Issa; Ladan Afifi; Caleb Jeon; Hsin Wen Chang; Wilson Liao
Journal:  Curr Dermatol Rep       Date:  2017-04-22

9.  Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.

Authors:  Nai-Lun Yeh; Che-Yuan Hsu; Tsen-Fang Tsai; Hsien-Yi Chiu
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

Review 10.  The skin microbiome: current perspectives and future challenges.

Authors:  Yiyin Erin Chen; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2013-03-13       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.